article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

article thumbnail

The Right Kind of Conflict Leads to Better Products

Harvard Business Review

” Members from each partner organization rate the alliance in areas related to strategic fit, operational fit, and cultural fit. Lilly trains its alliance managers to look at risk as the precursor to conflict, as parties typically engage in conflict as a method of reducing or controlling alliance risk.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Know If a Spin-Off Will Succeed

Harvard Business Review

Conversely, the business may be an “unpolished diamond” that was neglected by its former management for too long and whose value is just waiting to be unlocked. Does the business have a complete, balanced, and cohesive management team? Are the management team and owners prepared to abandon business as usual?

article thumbnail

How Microsoft Avoided the Peter Principle with Nadella

Harvard Business Review

And that question is likely to be answered in the affirmative if the directors have managed to avoid the Peter Principle. Great at mid-level, the managers were not game-ready for the next level. Or consider managed-health care provider Humana’s decision in 2013 to recruit an outsider as its next chief executive.

CEO 8